Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen Chung

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
International Journal of Cancer|September 24, 2021
Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutationChi-Hsien Huang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2024
High-Dimensional Single-Cell Multimodal Landscape of Human Carotid AtherosclerosisAlexander C Bashore, Hanying Yan, Chenyi Xue, et al.
Scientific Reports|November 21, 2023
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLCJia-Shiuan Ju, Allen Chung-Cheng Huang, Pi-Hung Tung, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLCPi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang, et al.
Thoracic Cancer|April 14, 2020
Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancerChia-Hsun Chu, Tzu-Hsuan Chiu, Chin-Chou Wang, et al.
Therapeutic Advances in Medical Oncology|July 28, 2022
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis studySuey-Haur Lee, Yu-Ching Lin, Li-Chung Chiu, et al.
Vaccines|May 25, 2024
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung CancerPing-Chih Hsu, Bing-Chen Wu, Chin-Chou Wang, et al.
Circulation Research|May 13, 2026
Atherosclerosis Profiling Reveals BHLHE40 as a Candidate Modulator of VSMCChinyere O Ibikunle, Enrique J Garcia, Chenyi Xue, et al.
Cell|April 6, 2019
Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA IsolationSrimeenakshi Srinivasan, Ashish Yeri, Pike See Cheah, et al.
Cell|April 6, 2019
exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human BiofluidsOscar D Murillo, William Thistlethwaite, Joel Rozowsky, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Cancer|September 24, 2021
Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutationChi-Hsien Huang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2024
High-Dimensional Single-Cell Multimodal Landscape of Human Carotid AtherosclerosisAlexander C Bashore, Hanying Yan, Chenyi Xue, et al.
Scientific Reports|November 21, 2023
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLCJia-Shiuan Ju, Allen Chung-Cheng Huang, Pi-Hung Tung, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLCPi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang, et al.
Thoracic Cancer|April 14, 2020
Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancerChia-Hsun Chu, Tzu-Hsuan Chiu, Chin-Chou Wang, et al.
Therapeutic Advances in Medical Oncology|July 28, 2022
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis studySuey-Haur Lee, Yu-Ching Lin, Li-Chung Chiu, et al.
Vaccines|May 25, 2024
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung CancerPing-Chih Hsu, Bing-Chen Wu, Chin-Chou Wang, et al.
Circulation Research|May 13, 2026
Atherosclerosis Profiling Reveals BHLHE40 as a Candidate Modulator of VSMCChinyere O Ibikunle, Enrique J Garcia, Chenyi Xue, et al.
Cell|April 6, 2019
Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA IsolationSrimeenakshi Srinivasan, Ashish Yeri, Pike See Cheah, et al.
Cell|April 6, 2019
exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human BiofluidsOscar D Murillo, William Thistlethwaite, Joel Rozowsky, et al.
Pageof 4